This bill amends various sections of Alaska's pharmacy laws to enhance the role of pharmacists in prescribing and administering medications, particularly in the context of pain management and opioid use. Key provisions include the requirement for pharmacists to complete training in pain management and opioid addiction as part of their licensure and continuing education. Additionally, the bill establishes standards for the independent prescribing and administration of vaccines and opioid overdose drugs, as well as the creation of a controlled substance prescription database to monitor prescriptions of controlled substances.

The bill also introduces changes to the qualifications for licensure by examination, including a new requirement for education in pain management and opioid use, and modifies the reciprocity process for pharmacists licensed in other jurisdictions to ensure they meet Alaska's standards. Furthermore, it clarifies the definition of "patient care services" to include the prescription or administration of drugs and devices, and emphasizes the need for pharmacists to recognize their professional limits and consult with other practitioners when necessary. The effective date for these changes is set for January 1, 2026.

Statutes affected:
HB0195A, AM HB 195, introduced 04/15/2025: 08.80.030, 17.30.200, 08.80.168, 17.22.020, 17.20.085, 08.80.159, 08.80.110, 08.80.145, 08.80.165, 08.80.337, 08.80.480